Dixit Ashutosh, Frampton Chris, Davey Valerie, Robinson Bridget, James Melissa
Christchurch Oncology Service, Canterbury Regional Cancer and Haematology Centre, Christchurch, New Zealand.
University of Otago, Christchurch, New Zealand.
J Med Imaging Radiat Oncol. 2019 Oct;63(5):698-706. doi: 10.1111/1754-9485.12933. Epub 2019 Aug 1.
We aimed to investigate the impact of radiation treatment in early-stage triple negative breast cancer (TNBC).
Patients with early stage (T1-3, N0-2, M0) TNBC were identified using the New Zealand breast cancer register. The outcomes of local recurrence (LRFR), local recurrence free survival (LRFS), loco-regional recurrence free rate (LRRFR), loco-regional recurrence free survival (LRRFS), breast cancer specific survival (BCSS), metastasis free (MFS) and overall survival (OS) were determined. Predefined univariate and multivariate cox regression analyses were used to explore associations between known prognostic and treatment factors.
1209 patients were identified with a median follow-up of 3.88 years. The majority were post- menopausal. The mean tumour size was 26mm, the majority had grade III disease and a third were node positive. 625 patients had mastectomy and 584 had breast conservation surgery (BCS). 92% of BCS and 38% of mastectomy patients received radiation. 67% received adjuvant chemotherapy. The 5 year OS was 77.6% (95% CI 74.6-80.2), 5 year BSS was 82.1% (95%CI 79.1-84.7), 5 year LRRFS was 73.9% (95% CI 73.87-73.93), 5 year LRFS was 75.4 (75.37-75.43) and the 5 year LRFR was 92.4% (95% CI 90.6-94.2). The significant prognostic/predictive factors for OS were adjuvant radiation treatment, chemotherapy, T stage, lymph node involvement and lympho-vascular space invasion. Results were similar for BSS, DMFS, LRFS and LRRFS except that LVSI was not significantly associated with BCSS, LRFS or LRRFS. When analysed by surgical type, in the WLE group, radiation was found to be significantly associated with improvement in all outcomes. In mastectomy group, radiation was not found to be significant for BCSS, LRFS, LRRFS or OS.
Radiation treatment is significantly associated with improved outcomes in early stage TNBC. This argues against the hypothesis that TNBC has inherent radiation resistance.
我们旨在研究放射治疗对早期三阴性乳腺癌(TNBC)的影响。
利用新西兰乳腺癌登记处确定早期(T1 - 3,N0 - 2,M0)TNBC患者。确定局部复发率(LRFR)、无局部复发生存率(LRFS)、区域无复发生存率(LRRFR)、区域无复发生存期(LRRFS)、乳腺癌特异性生存率(BCSS)、无远处转移生存率(MFS)和总生存率(OS)。使用预定义的单变量和多变量cox回归分析来探讨已知预后因素和治疗因素之间的关联。
共确定1209例患者,中位随访时间为3.88年。大多数为绝经后患者。平均肿瘤大小为26mm,大多数为Ⅲ级疾病,三分之一有淋巴结转移。625例患者接受了乳房切除术,584例接受了保乳手术(BCS)。92%的保乳手术患者和38%的乳房切除术患者接受了放疗。67%的患者接受了辅助化疗。5年总生存率为77.6%(95%CI 74.6 - 80.2),5年乳腺癌特异性生存率为82.1%(95%CI 79.1 - 84.7),5年区域无复发生存率为73.9%(95%CI 73.87 - 73.93),5年无局部复发生存率为75.4(75.37 - 75.43),5年局部复发率为92.4%(95%CI 90.6 - 94.2)。总生存率的显著预后/预测因素为辅助放疗、化疗、T分期、淋巴结受累和淋巴管侵犯。BCSS、DMFS、LRFS和LRRFS的结果相似,只是淋巴管侵犯与BCSS、LRFS或LRRFS无显著关联。按手术类型分析时,在保乳手术组中,放疗与所有结局的改善显著相关。在乳房切除术组中,放疗对BCSS、LRFS、LRRFS或OS无显著影响。
放射治疗与早期TNBC结局改善显著相关。这与TNBC具有内在放射抗性的假设相悖。